BioNexus Gene Lab (BGLC) FCF Margin (2018 - 2026)
BioNexus Gene Lab's (BGLC) quarterly FCF Margin came in at 555.1% in Q2 2026, down 52150.0% year-over-year from N/an in Q2 2025, and up 14.32% quarter-over-quarter from 647.91% in Q1 2026.
Analysis
BioNexus Gene Lab (BGLC) FCF Margin (2018 - 2026) Analysis & Trends
BioNexus Gene Lab has disclosed FCF Margin across 9 years of filings, most recently posting 555.1% for Q2 2026.
- In Q2 2026, FCF Margin fell 52150.0% year-over-year to 555.1%; the TTM figure through Jun 2026 stood at 27.3% (up 599.0% YoY), while the FY2025 annual figure was 25.26%, down 86.0% from the prior year.
- FCF Margin came in at 555.1% for Q2 2026 at BioNexus Gene Lab, up from 647.91% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 198.46% in Q4 2025 to a low of 647.91% in Q1 2026.
- Average FCF Margin over 5 years is 72.65%, with a median of 17.65% recorded in 2024.
- Year-over-year, FCF Margin soared 18994 bps in 2025 and sank 60893 bps in 2026.
- Over 5 years, FCF Margin stood at 0.08% in 2022, then tumbled by 46417 bps to 35.51% in 2023, then surged by 124 bps to 8.53% in 2024, then soared by 2228 bps to 198.46% in 2025, then sank by 380 bps to 555.1% in 2026.
- Per Business Quant data, the three most recent FCF Margin figures were 555.1% in Q2 2026, 647.91% in Q1 2026, and 198.46% in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | W.W. Grainger | 62.38 Bn | 62.17 Bn | 1.98 Bn | 6.63% |
| 2 | Fastenal | 56.92 Bn | 56.71 Bn | 1.06 Bn | 8.45% |
| 3 | Ferguson Enterprises | 44.34 Bn | 43.52 Bn | 2.32 Bn | 9.10% |
| 4 | Reliance | 20.45 Bn | 20.23 Bn | 1.30 Bn | 1.49% |
| 5 | Wesco International | 17.12 Bn | 16.31 Bn | 1.46 Bn | 0.38% |
| 6 | Applied Industrial Technologies | 11.98 Bn | 11.86 Bn | 411.22 Mn | 11.81% |
| 7 | Watsco | 11.22 Bn | 11.23 Bn | 578.93 Mn | -0.55% |
| 8 | Avantor | 10.13 Bn | 9.82 Bn | 537.00 Mn | 8.31% |
| 9 | Core & Main | 8.33 Bn | 8.25 Bn | 520.00 Mn | 3.56% |
| 10 | BioNexus Gene Lab | 2.60 Mn | -922,180.04 | 12,982.00 | -555.10% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -555.10% |
| Mar 31, 2026 | -647.91% |
| Dec 31, 2025 | 198.46% |
| Sep 30, 2025 | -48.86% |
| Jun 30, 2025 | -33.60% |
| Mar 31, 2025 | -38.98% |
| Dec 31, 2024 | 8.53% |
| Sep 30, 2024 | -68.52% |
| Jun 30, 2024 | -26.43% |
| Mar 31, 2024 | -8.88% |
| Dec 31, 2023 | -35.51% |
| Sep 30, 2023 | -45.18% |
| Jun 30, 2023 | -2.02% |
| Mar 31, 2023 | -5.48% |
| Dec 31, 2022 | 0.08% |
| Sep 30, 2022 | 11.85% |
| Jun 30, 2022 | -7.94% |
| Mar 31, 2022 | -2.31% |
| Dec 31, 2021 | 14.84% |
| Sep 30, 2021 | 8.82% |